Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bellemore

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Clinical and Experimental Immunology|October 27, 2015
Pathogenic T helper type 17 cells contribute to type 1 diabetes independently of interleukin-22S M Bellemore, E Nikoopour, O Krougly, et al.
Clinical and Experimental Immunology|May 3, 2014
Anti-atherogenic peptide Ep1.B derived from apolipoprotein E induces tolerogenic plasmacytoid dendritic cellsS M Bellemore, E Nikoopour, B C Y Au, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Clinical and Experimental Immunology|October 27, 2015
Pathogenic T helper type 17 cells contribute to type 1 diabetes independently of interleukin-22S M Bellemore, E Nikoopour, O Krougly, et al.
Clinical and Experimental Immunology|May 3, 2014
Anti-atherogenic peptide Ep1.B derived from apolipoprotein E induces tolerogenic plasmacytoid dendritic cellsS M Bellemore, E Nikoopour, B C Y Au, et al.
Pageof 2